Orphan drug specialist Amicus Therapeutics is paying Dimerix $30 million cash for U.S. rights to the phase 3 prospect DMX-200 ...

From sweet treats to cold medicine, Red Dye No. 3 has been a popular food additive ingredient for decades. Now, it's under scrutiny.

The FDA’s decision to ban dyes and other synthetic substances often rests on the Delaney clause, a 49‑word law from 1958 that ...

The ASX has been up 0.2% at around 8,140 points in morning trade. Dimerix (ASX:DMX) has rocketed up around 47% and is the ...